Martin Sebastian  Olivo net worth and biography

Martin Olivo Biography and Net Worth

Dr. Martin Olivo is the Insider of Protara Therapeutics. They are 48 years old.

What is Martin Sebastian Olivo's net worth?

The estimated net worth of Martin Sebastian Olivo is at least $37,734.10 as of June 10th, 2021. Dr. Olivo owns 9,410 shares of Protara Therapeutics stock worth more than $37,734 as of March 29th. This net worth estimate does not reflect any other investments that Dr. Olivo may own. Learn More about Martin Sebastian Olivo's net worth.

How do I contact Martin Sebastian Olivo?

The corporate mailing address for Dr. Olivo and other Protara Therapeutics executives is 1 LITTLE WEST 12TH STREET, NEW YORK NY, 10014. Protara Therapeutics can also be reached via phone at (646) 844-0337 and via email at [email protected]. Learn More on Martin Sebastian Olivo's contact information.

Has Martin Sebastian Olivo been buying or selling shares of Protara Therapeutics?

Martin Sebastian Olivo has not been actively trading shares of Protara Therapeutics during the last quarter. Most recently, on Thursday, June 10th, Martin Sebastian Olivo bought 9,893 shares of Protara Therapeutics stock. The stock was acquired at an average cost of $10.10 per share, with a total value of $99,919.30. Following the completion of the transaction, the insider now directly owns 9,410 shares of the company's stock, valued at $95,041. Learn More on Martin Sebastian Olivo's trading history.

Martin Sebastian Olivo Insider Trading History at Protara Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/10/2021Buy9,893$10.10$99,919.309,410View SEC Filing Icon  
See Full Table

Martin Sebastian Olivo Buying and Selling Activity at Protara Therapeutics

This chart shows Martin Sebastian Olivo's buying and selling at Protara Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Protara Therapeutics Company Overview

Protara Therapeutics logo
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. The company is headquartered in New York, New York.
Read More

Today's Range

Now: $4.01
Low: $3.95
High: $4.10

50 Day Range

MA: $3.45
Low: $1.86
High: $4.83

2 Week Range

Now: $4.01
Low: $1.04
High: $4.95

Volume

83,563 shs

Average Volume

79,090 shs

Market Capitalization

$45.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69